Yahoo Poland Wyszukiwanie w Internecie

Search results

1. www.ncbi.nlm.nih.gov › pmc › articlesMemantine for the Treatment of Dementia: A Review on its Current...

   www.ncbi.nlm.nih.gov › pmc › articles

   13 mar 2018 · The discovery of extrasynaptic NMDARs provided a rational and physiological explanation between physiological and excitotoxic actions of glutamate. Memantine (MEM), an antagonist of extrasynaptic NMDAR, is currently used for the treatment of AD jointly with acetylcholinesterase inhibitors.

2. pubmed.ncbi.nlm.nih.gov › 29254093Memantine for the Treatment of Dementia: A Review on its ... -...

   pubmed.ncbi.nlm.nih.gov › 29254093

   Memantine (MEM), an antagonist of extrasynaptic NMDAR, is currently used for the treatment of AD jointly with acetylcholinesterase inhibitors. It has been demonstrated that MEM preferentially prevents the excessive continuous extrasynaptic NMDAR disease activation and therefore prevents neuronal cell death induced by excitotoxicity without ...

3. www.ncbi.nlm.nih.gov › pmc › articlesBasic information about memantine and its treatment of...

   www.ncbi.nlm.nih.gov › pmc › articles

   6 cze 2023 · Memantine is a noncompetitive moderate‐affinity strong voltage‐dependent N‐methyl‐D‐aspartate receptor antagonist. It has been used to treat Alzheimer's disease (AD) since 1989. In 2018, it became the second most commonly used drug for the treatment of dementia in the world.

4. www.ncbi.nlm.nih.gov › pmc › articlesMemantine, Donepezil, or Combination Therapy—What is the best...

   www.ncbi.nlm.nih.gov › pmc › articles

   10 wrz 2020 · Memantine and donepezil are frequently used in its treatment, both as monotherapy and in combination. This multiple treatment comparison meta‐analysis assessed the efficacy of these regimens and placebo in the management of AD.

5. link.springer.com › referenceworkentry › 10Memantine for Treatment of Dementia | SpringerLink

   link.springer.com › referenceworkentry › 10

   • Zapisane w pamięci cache

   5 lis 2022 · The N-methyl-D-Aspartate receptor antagonist memantine with its less popular monoamine reuptake-inhibiting properties provides beneficial effects in patients with advanced Alzheimer’s disease on an acetylcholine esterase inhibitor treatment regimen.

6. www.webmd.com › alzheimers › medicines-to-treat-dementiaAlzheimer’s Disease Medication - WebMD

   www.webmd.com › alzheimers › medicines-to-treat-dementia

   • Zapisane w pamięci cache

   3 lip 2024 · Alzheimer’s disease doesn’t have a cure, and there aren’t yet treatments that can stop its progression, but there are Alzheimer’s drugs that can help people with their memory and thinking...

7. www.england.nhs.uk › london › wp-contentMemantine for dementia what, why, who and when? - NHS England

   www.england.nhs.uk › london › wp-content

   The new dementia NICE guidelines published in June 2018 state that we should consider memantine for patients with moderate Alzheimer’s Disease and offer memantine for people with severe Alzheimer’s Disease, and if the person is already taking acetylcholinesterase inhibitors primary care prescribers may start treatment with memantine without taki...